Stay updated on B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.

Latest updates to the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page shows a revision update from v3.3.1 to v3.3.2, indicating a minor version change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check22 days agoChange DetectedMinor UI change updating the page revision from v3.2.0 to v3.3.1 at the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check29 days agoChange DetectedFunding/operating status banner has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check44 days agoChange DetectedNo significant changes detected between the two screenshots; the page content appears unchanged.SummaryDifference0.3%

- Check72 days agoChange DetectedUpgrade to v3.2.0 with a new government-operating status notice and funding caveat; removes v3.1.0. This introduces current-operational caveats and directs users to status pages.SummaryDifference3%

- Check80 days agoChange DetectedUpdate: Revision from v3.0.2 to v3.1.0. This is a versioning change with no other substantive content alterations.SummaryDifference0.1%

Stay in the know with updates to B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.